“Rise in incidence of arthritis, increase in geriatric population, high demand for topical pain relief products by sportsperson and lesser side effects caused by topical pain relief products as compared to oral medicines fuel the growth of the U.S. topical pain relief market.”
The U.S. Topical Pain Relief Market was estimated at $2.32 billion in 2017 and is expected to hit $3.73 billion by 2025, registering a CAGR of 6.0% from 2018 to 2025. The report provides an in-depth analysis of top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive scenario, and changing market trends.
Increase in incidence of arthritis, surge in geriatric population, high demand for topical pain relief products by sportsperson and lesser side effects caused by topical pain relief products as compared to oral medicines propel the growth of the U.S. topical pain relief market. On the other hand, unpleasant odor and risk for skin irritation restrain the growth to certain extent. However, emergence of online pharmacy is expected to create a number of opportunities for the key players in the industry.
Download the Sample Report @ https://www.alliedmarketresearch.com/request-sample/5356
Non-opioids segment to dominate by 2025-
Based on therapeutic class, the non-opioids segment contributed to nearly three-fourths of the total share in 2017 and is expected to dominate by 2025. This segment would also showcase the CAGR of 6.2% throughout 2018–2025.
The cream segment to rule the roost throughout the forecast period-
Based on formulation, the cream segment garnered the highest share in 2017, holding nearly two-fifths of the total market share. The patch segment, on the other hand, would cite the fastest CAGR of 7.6% during the estimated period.
The pharmacies & drug stores segment to retain its dominance till 2025-
Based on distribution channels, the pharmacies & drug stores segment accounted for nearly fourth-fifths of the total market revenue in 2017 and is anticipated to lead the trail throughout the study period.
Check available discounts on this report at: https://www.alliedmarketresearch.com/purchase-enquiry/5356
Leading market players-
The key market players analyzed in the U.S. topical pain relief market report include Novartis AG, Reckitt Benckiser Group Plc., Nestle S.A., AdvaCare Pharma, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Johnson & Johnson, Topical BioMedics, Inc., Sanofi S.A., and GlaxoSmithKline Plc. These market players have incorporated several strategies including partnership, expansion, collaboration, joint ventures, and others to heighten their stand in the industry.
Scope of the Report:
|Market size available for years||2018 – 2025|
|Base year considered||2019|
|Forecast period||2019 – 2025|
|Forecast units||Value (USD)|
|Segments covered||By Therapeutic Class, Type, Formulation and Distribution Channel|
|Geographies covered||United States|
Topical Pain Relief Market by Therapeutic Class (Non-Opioids and Opioids), Type (Prescription Pain Relief and Over-the-Counter Pain Relief), Formulation (Cream, Gel, Spray, Patch, and Others) and Distribution Channel (Pharmacies & Drug Stores, e-Commerce, and Retail & Grocery Stores) – Global Opportunity Analysis and Industry Forecast, 2018-2025
Topical Pain Relief Cream Market by Brand (Ultra-Strength Cream, Icy Hot Cream, The Rub, Capzasin-Hp Cream, Aspercreme, Sportscreme, Myoflex Cream, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free: +1-800-792-5285
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060